This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2013-2019.
Location History:
- Mishima, JP (2018)
- Sunto-gun, JP (2013 - 2019)
Company Filing History:
Years Active: 2013-2019
Title: Masashi Nakakura: Innovator in Antibody Stabilization and Fine Particle Production
Introduction
Masashi Nakakura is a prominent inventor based in Sunto-gun, Japan. He has made significant contributions to the field of biotechnology, particularly in the stabilization of antibodies and the production of fine particles. With a total of 4 patents to his name, Nakakura's work has the potential to impact various applications in medicine and materials science.
Latest Patents
One of Nakakura's latest patents is a method of stabilizing antibodies and creating stabilized solution-type antibody preparations. This invention provides a method to suppress the formation of soluble associations and chemically degraded products of antibodies in solution. Additionally, it offers a stabilizing agent for antibodies, enhancing their effectiveness in therapeutic applications. Another notable patent involves a method of producing fine particles that are surface-modified with water-soluble substances. This method simplifies the production process of fine particles comprising lipids or fatty acids, which can be beneficial in various industrial applications.
Career Highlights
Masashi Nakakura is associated with Kyowa Hakko Kirin Co., Limited, a company known for its innovative approaches in biotechnology and pharmaceuticals. His work at the company has allowed him to focus on developing solutions that address critical challenges in antibody stability and particle production.
Collaborations
Throughout his career, Nakakura has collaborated with notable colleagues, including Yuji Ueno and Takashi Kayashita. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Masashi Nakakura's contributions to the fields of antibody stabilization and fine particle production highlight his innovative spirit and dedication to advancing biotechnology. His patents reflect a commitment to solving complex problems and improving the efficacy of biopharmaceuticals.